Sol-Millennium® Medical Group, a leading manufacturer of medical devices, has launched an innovative needle-free injection ...

Researchers at the Massachusetts Institute of Technology (MIT), led by Giovanni Traverso, developed a microjet system ...

The device, which directs a liquid by mimicking squids’ high-pressure jets, could provide alternative delivery methods for injectable drugs.

Cipla receives approval to market Afrezza, a rapid-acting insulin inhaler, offering a needle-free solution for diabetes ...

Microjet delivery systems that are inspired by cephalopods’ propulsion methods enable the needle-free administration ... deliver macromolecules such as insulin, analogues of the appetite ...

For decades, needle-based injections have been the main method for delivering large biological molecules such as insulin and vaccine components, but an aversion to needles is a significant reason ...

Using jet propulsion inspired by squid, researchers demonstrate a microjet system that delivers medications directly into tissues, matching the effectiveness of traditional needles. In a recent ...

an aversion to needles leads one in six American adults to skip vaccinations, and is an important reason why people who rely on injectable drugs such as insulin fail to keep up with their dosage.

MIT News says it can deliver insulin, antibodies and vaccines. Also, it can become a more sustainable alternative because it won’t require disposable needles. MIT engineers designed an ...